Olix and Lilly Sign Global Deal for Mash and Cardiometabolic
February 11, 2025
OliX to Receive Initial Payment and Complete Phase 1 Clinical Trial in Australia OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, announced a global